Stocktoria
BeyondSpring Inc. BYSI
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2017-03-09
BeyondSpring Inc. statistics & valuation
Market cap$69.5M
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Operating margin | — | — | — | -2756.4% | -4903.0% |
| Net margin | — | — | — | -2463.3% | -4750.5% |
| FCF margin | — | — | — | -2035.4% | -3707.3% |
| Return on assets | -3.9% | -32.4% | -84.8% | -72.0% | -78.6% |
| Return on equity | 3.1% | 33.8% | 59.5% | 236.3% | -240.5% |
| Debt / equity | — | — | — | — | 0.00× |
| Current ratio | 1.54 | 2.60 | 2.31 | 5.24 | 4.96 |
| Revenue growth | — | — | -100.0% | 0.0% | 650.6% |
Source: SEC EDGAR filings · CIK 0001677940 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.